Mr. Kleckner’s background comprises 26 years on senior level operations, general management, marketing and business development in the life sciences, oil & gas, cable television, counter-intelligence and aerospace. His current work encompasses guiding emerging and established companies with corporate planning and strategy, commercialization and business development, marketing, and public policy throughout Europe, Asia & the Americas. He is a co-founder of RefluxMD.com, a Health 2.0 Internet company specializing in gastroesophageal reflux disease. Previously he was Chief Executive Officer for U P Laboratories in San Diego for the development of proprietary synthetic peptides (excitation secretion uncoupling peptides) as an alternative to botulinum neurotoxin (BoTox®) for topical anti-aging/wrinkle inhibition and hyperhidrosis.